Pre-Clinical Intravenous Serum Pharmacokinetics of Albumin Binding and Non-Half-Life Extended Nanobodies® †
Hoefman, S.; Ottevaere, I.; Baumeister, J.; Sargentini-Maier, M.L. Pre-Clinical Intravenous Serum Pharmacokinetics of Albumin Binding and Non-Half-Life Extended Nanobodies®. Antibodies 2015, 4, 141-156. https://doi.org/10.3390/antib4030141
Hoefman S, Ottevaere I, Baumeister J, Sargentini-Maier ML. Pre-Clinical Intravenous Serum Pharmacokinetics of Albumin Binding and Non-Half-Life Extended Nanobodies®. Antibodies. 2015; 4(3):141-156. https://doi.org/10.3390/antib4030141
Chicago/Turabian StyleHoefman, Sven, Ingrid Ottevaere, Judith Baumeister, and Maria L. Sargentini-Maier. 2015. "Pre-Clinical Intravenous Serum Pharmacokinetics of Albumin Binding and Non-Half-Life Extended Nanobodies®" Antibodies 4, no. 3: 141-156. https://doi.org/10.3390/antib4030141